Donna McEachern
Impact in
- Oncology top 1%
- Peptidase Inhibition and Analysis
- Cancer-related Molecular Pathways
- Hematology top 2%
- Multiple Myeloma Research and Treatments
Papers in
-
- Protein Degradation and Inhibitors 32
- Ubiquitin and proteasome pathways 30
- Cell death mechanisms and regulation 11
- Oncology 39
- Peptidase Inhibition and Analysis 15
- Cancer-related Molecular Pathways 14
- Cancer Cells and Metastasis 5
- Co-authors
- Shaomeng Wang (58 shared papers)Liu Liu (21 shared papers)Duxin Sun (28 shared papers)Chao‐Yie Yang (20 shared papers)Longchuan Bai (32 shared papers)Jianfeng Lü (17 shared papers)Bo Wen (22 shared papers)Yujun Zhao (9 shared papers)
- Journals
- Journal of Medicinal Chemistry (34 papers)Cancer Research (7 papers)Molecular Cancer Therapeutics (5 papers)European Journal of Cancer (4 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Donna McEachern
72 papers receiving 4.3k citations
Donna McEachern's Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 1.5k
- Hematology 560
- Molecular Biology 2.9k
- Organic Chemistry 884
- Toxicology 92
Countries citing papers authored by Donna McEachern
This map shows the geographic impact of Donna McEachern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna McEachern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna McEachern more than expected).
Fields of papers citing papers by Donna McEachern
This network shows the impact of papers produced by Donna McEachern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna McEachern. The network helps show where Donna McEachern may publish in the future.
Co-authors
The 25 scholars most cited alongside Donna McEachern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo Hit paper breakdown → | 2019 | 465 |
| 2 | 2017 | 293 | |
| 3 | 2018 | 251 | |
| 4 | 2013 | 249 | |
| 5 | 2011 | 226 | |
| 6 | 2013 | 204 | |
| 7 | 2008 | 182 | |
| 8 | 2019 | 178 | |
| 9 | 2017 | 173 | |
| 10 | 2009 | 156 | |
| 11 | Sensitivity of human cells to mild hyperthermia. | 1993 | 122 |
| 12 | 2021 | 114 | |
| 13 | 2021 | 108 | |
| 14 | 2018 | 92 | |
| 15 | 2008 | 78 | |
| 16 | 2014 | 71 | |
| 17 | 2014 | 66 | |
| 18 | 2020 | 63 | |
| 19 | 2011 | 57 | |
| 20 | Growth regulation of mouse mammary tumor cells in collagen gel cultures by diffusible factors produced by normal mammary gland epithelium and stromal fibroblasts. | 1989 | 56 |
About Donna McEachern
Donna McEachern is a scholar working on Molecular Biology, Oncology, Hematology, Organic Chemistry and Cell Biology, having authored 74 papers that have together received 4.3k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (32 papers), Ubiquitin and proteasome pathways (30 papers), Peptidase Inhibition and Analysis (15 papers), Cancer-related Molecular Pathways (14 papers), Multiple Myeloma Research and Treatments (12 papers), Cell death mechanisms and regulation (11 papers), Microtubule and mitosis dynamics (5 papers) and Cancer Cells and Metastasis (5 papers). The work is most often cited by research in Oncology (1.5k citations), Hematology (560 citations), Molecular Biology (2.9k citations), Organic Chemistry (884 citations) and Toxicology (92 citations). Donna McEachern has collaborated with scholars based in United States, China and France. Frequent co-authors include Shaomeng Wang, Liu Liu, Duxin Sun, Chao‐Yie Yang, Longchuan Bai, Jianfeng Lü, Bo Wen, Yujun Zhao, Jeanne A. Stuckey and Mi Wang. Their work appears in journals such as Journal of Medicinal Chemistry, Cancer Research, Molecular Cancer Therapeutics, European Journal of Cancer and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.